• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与病毒衣壳结合时抑制脱壳的抗病毒剂的结构。

The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.

作者信息

Rossmann M G

机构信息

Department of Biological Sciences, Purdue University, West Lafayette, Indiana.

出版信息

Antiviral Res. 1989 Feb;11(1):3-13. doi: 10.1016/0166-3542(89)90016-8.

DOI:10.1016/0166-3542(89)90016-8
PMID:2540708
Abstract

The tertiary structure of most icosahedral viral capsid proteins consists of an eight-stranded antiparallel beta-barrel with a hydrophobic interior. In a group of picornaviruses, this hydrophobic pocket can be filled by suitable organic molecules, which stop viral uncoating after attachment and penetration into the host cell. The antiviral activity of these agents is probably due to increased rigidity of the capsid protein, thereby inhibiting disassembly. The hydrophobic pocket may be an essential functional component of the protein and may have been conserved in the evolution of many viruses from a common precursor. Since eight-stranded anti-parallel beta-barrels, with a topology as in viral capsid proteins, are not generally found in other proteins involved in cell metabolism, antiviral agents that bind in the interior of viral capsid proteins are likely to be more virus-specific and less cytotoxic. Furthermore, the greatest conservation of viral capsid proteins occurs within this pocket, whereas the least conserved part is the antigenic exterior. Thus, compounds that bind to such a pocket are likely to be effective against a broader group of serologically distinct viruses. Discovery of antiviral agents of this type depends on designing compounds that can enter and fit snugly into the hydrophobic pocket of a particular viral capsid protein.

摘要

大多数二十面体病毒衣壳蛋白的三级结构由一个具有疏水内部的八链反平行β桶组成。在一组小核糖核酸病毒中,这个疏水口袋可以被合适的有机分子填充,这些分子在病毒附着并侵入宿主细胞后阻止病毒脱壳。这些药物的抗病毒活性可能是由于衣壳蛋白的刚性增加,从而抑制了病毒的解体。疏水口袋可能是该蛋白的一个重要功能组件,并且可能在许多病毒从共同前体进化的过程中得以保留。由于具有与病毒衣壳蛋白相同拓扑结构的八链反平行β桶在参与细胞代谢的其他蛋白中一般不存在,因此结合在病毒衣壳蛋白内部的抗病毒药物可能更具病毒特异性且细胞毒性更小。此外,病毒衣壳蛋白的最大保守区域出现在这个口袋内,而最不保守的部分是抗原性外部。因此,与这样一个口袋结合的化合物可能对更广泛的血清学不同的病毒有效。这类抗病毒药物的发现取决于设计能够进入并紧密契合特定病毒衣壳蛋白疏水口袋的化合物。

相似文献

1
The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.与病毒衣壳结合时抑制脱壳的抗病毒剂的结构。
Antiviral Res. 1989 Feb;11(1):3-13. doi: 10.1016/0166-3542(89)90016-8.
2
Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.靶向与病毒衣壳蛋白相互作用的抗病毒药物及其在人类免疫缺陷病毒中的可能应用。
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4625-7. doi: 10.1073/pnas.85.13.4625.
3
The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.人鼻病毒16型在2.15埃分辨率下的精细结构:对病毒生命周期的影响。
Structure. 1997 Mar 15;5(3):427-41. doi: 10.1016/s0969-2126(97)00199-8.
4
Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.耐培拉韦鼻病毒-B5 复合物的冷冻电镜结构揭示了抗病毒药物 OBR-5-340 的意想不到的结合位点。
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19109-19115. doi: 10.1073/pnas.1904732116. Epub 2019 Aug 28.
5
Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.一系列与人类鼻病毒14复合的抗病毒药物的结构分析
Proc Natl Acad Sci U S A. 1988 May;85(10):3304-8. doi: 10.1073/pnas.85.10.3304.
6
A novel basis of capsid stabilization by antiviral compounds.抗病毒化合物稳定衣壳的新机制。
J Mol Biol. 1995 Dec 8;254(4):544-51. doi: 10.1006/jmbi.1995.0637.
7
Structural studies on human rhinovirus 14 drug-resistant compensation mutants.人鼻病毒14耐药补偿突变体的结构研究
J Mol Biol. 1995 Oct 13;253(1):61-73. doi: 10.1006/jmbi.1995.0536.
8
Human rhinovirus 14 complexed with fragments of active antiviral compounds.与活性抗病毒化合物片段复合的人鼻病毒14型
Virology. 1994 Jul;202(1):360-9. doi: 10.1006/viro.1994.1352.
9
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.与人类鼻病毒衣壳相互作用的抗病毒药物的结构分析。
Proteins. 1989;6(1):1-19. doi: 10.1002/prot.340060102.
10
Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.对普通感冒病毒——人鼻病毒14的结构分析,分辨率为3.0埃。
J Mol Biol. 1990 Feb 20;211(4):763-801. doi: 10.1016/0022-2836(90)90076-x.

引用本文的文献

1
Rhinovirus Inhibitors: Including a New Target, the Viral RNA.鼻病毒抑制剂:包括一个新的靶点,病毒 RNA。
Viruses. 2021 Sep 7;13(9):1784. doi: 10.3390/v13091784.
2
Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies.迈向针对鼻病毒引起的慢性阻塞性肺疾病加重的抗病毒治疗/预防:挑战、机遇与策略
Rev Med Virol. 2016 Jan;26(1):21-33. doi: 10.1002/rmv.1856. Epub 2015 Sep 21.
3
Protein-Protein Interfaces in Viral Capsids Are Structurally Unique.
病毒衣壳中的蛋白质-蛋白质界面在结构上具有独特性。
J Mol Biol. 2015 Nov 6;427(22):3613-3624. doi: 10.1016/j.jmb.2015.09.008. Epub 2015 Sep 12.
4
Picornavirus morphogenesis.小核糖核酸病毒形态发生
Microbiol Mol Biol Rev. 2014 Sep;78(3):418-37. doi: 10.1128/MMBR.00012-14.
5
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.一种具有抗人鼻病毒临床活性的口服可用的3-乙氧基苯并异恶唑衣壳结合剂。
ACS Med Chem Lett. 2012 Feb 13;3(4):303-7. doi: 10.1021/ml2002955. eCollection 2012 Apr 12.
6
Complete coding sequence characterization and comparative analysis of the putative novel human rhinovirus (HRV) species C and B.鉴定并比较新型人鼻病毒(HRV)C 种和 B 种的完整编码序列。
Virol J. 2011 Jan 7;8:5. doi: 10.1186/1743-422X-8-5.
7
The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.人类鼻病毒:对人类的病理影响、抗鼻病毒药物的作用机制及研发策略。
Med Res Rev. 2011 Jan;31(1):42-92. doi: 10.1002/med.20176.
8
Tripeptide interference with human immunodeficiency virus type 1 morphogenesis.三肽对1型人类免疫缺陷病毒形态发生的干扰。
Antimicrob Agents Chemother. 2002 Nov;46(11):3597-605. doi: 10.1128/AAC.46.11.3597-3605.2002.
9
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.双环胺衍生物JM3100对人类免疫缺陷病毒的高效选择性抑制作用
Antimicrob Agents Chemother. 1994 Apr;38(4):668-74. doi: 10.1128/AAC.38.4.668.
10
Modification of membrane permeability by animal viruses.动物病毒对膜通透性的改变。
Adv Virus Res. 1995;45:61-112. doi: 10.1016/s0065-3527(08)60058-5.